Communicating in the Aftermath of ‘Repeal and Replace’
Today’s effective communicators must be comfortable with change, learn how to anticipate it, and adapt messaging to key audiences.
Today’s effective communicators must be comfortable with change, learn how to anticipate it, and adapt messaging to key audiences.
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
Kevin Griffis brought his experience in government and politics to Planned Parenthood at the perfect time, leading the fight to protect birth control coverage under the Trump administration and destigmatizing abortion.
It turns out the real goal is going after Washington’s favorite whipping boy — high drug prices.
Although it’s a long way from the president’s desk, the Tax Cut and Jobs Act of 2017 contains plenty of good news for the life sciences industry and its marketing partners.
The first year of the Trump administration was kind to pharma, but it might not be so fortunate in 2018.
Pfizer Q3 revenue driven by Prevnar sales; President Trump’s opioid panel presents draft to combat crisis; Novartis seeks FDA approval for CAR-T therapy Kymriah
Do you recall what President Trump tweeted right after Merck’s Kenneth Frazier resigned from his American Manufacturing Council?
Merck CEO Kenneth Frazier’s exit from a presidential manufacturing council may go down as one of the most principled stands by the CEO of a major U.S. company, let alone a drugmaker.
It’s not often that pharmaceutical companies are held up as examples of morality or leadership to the general public.